Last reviewed: June 18, 2026
Last updated: June 18, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in Ozempic, has demonstrated consistent weight loss results in clinical trials, with participants losing an average of 15% of their starting body weight over 68 weeks. Real-world outcomes depend on multiple factors including your starting weight, adherence to treatment, dietary habits, and individual metabolic differences. Understanding what typical weight loss looks like helps you set realistic goals and evaluate whether this therapy is right for you.
Average Weight Loss Results with Semaglutide Treatment
Clinical trials show that patients taking semaglutide lose significantly more weight than those on placebo. In the landmark STEP trials, participants achieved average weight losses ranging from 9.2% to 17.4% of their baseline body weight depending on the dose and duration of treatment. For a person weighing 250 pounds, this translates to losing 23 to 44 pounds over the course of the study period.
Weight loss typically accelerates during the first three to four months as your body adjusts to the medication and your appetite naturally decreases. Many patients report noticeable changes in hunger levels and food preferences within the first few weeks, which supports earlier dietary changes. The rate of weight loss may stabilize or slow after the initial months, but continued progress is common as long as treatment continues and lifestyle habits remain consistent.
Dose escalation plays a role in overall weight loss outcomes. Starting with a lower dose allows your body to adapt while minimizing side effects, and gradual increases help your system adjust to higher therapeutic doses. However, PlexusDx ensures that your dose may go up, but your price won't—treatment costs remain consistent regardless of dose level.
Factors That Influence Individual Weight Loss on Semaglutide
Genetic variations significantly affect how your body processes GLP-1 medications and responds to treatment. Key genetic markers in the GLP1R and GIPR genes influence receptor sensitivity and appetite signaling, meaning some individuals naturally see faster results than others taking the same dose. The PlexusDx Precision Peptide Genetic Test analyzes 14 metabolic pathways and 49 peptides to identify your genetic predispositions, helping predict your likely response pattern before starting therapy.
Your starting body weight and overall metabolic health shape weight loss trajectory. Patients with higher initial weights often experience larger absolute weight losses, while those with slower metabolisms may require dose adjustments or combined approaches to achieve optimal results. Lifestyle factors including diet quality, physical activity level, sleep patterns, and stress management directly impact how effectively semaglutide works alongside medication.
Age and existing health conditions also influence outcomes. Younger patients and those without significant metabolic disorders often see faster initial weight loss, while older adults or those with diabetes may experience different response patterns. Individual consistency with injections, adherence to eating guidelines, and regular physical activity remain among the most controllable factors affecting your personal results.
How Compounded Semaglutide Compares to Brand-Name Ozempic
Compounded semaglutide from licensed 503A pharmacies contains the same active pharmaceutical ingredient as brand-name Ozempic, delivering equivalent weight loss results when dosed appropriately. The difference lies in cost and accessibility: PlexusDx compounded semaglutide injections start at just $149 per month, compared to thousands of dollars monthly for brand-name versions, making this proven therapy accessible without insurance coverage.
PlexusDx sources all compounded medications exclusively from licensed 503A compounding pharmacies that follow strict FDA oversight and quality standards. This ensures the purity, potency, and safety of each dose matches what you would receive from a traditional pharmaceutical manufacturer. Patients switching from brand-name Ozempic to compounded semaglutide maintain consistent weight loss trajectories, confirming bioequivalence in real-world practice.
Realistic Expectations: Timelines and Maintenance Weight Loss
Most patients notice appetite suppression within 7-14 days of their first injection, though significant weight loss typically becomes measurable after 4-8 weeks of consistent treatment. Monthly weigh-ins help track progress, but fluctuations of 2-3 pounds week-to-week are normal and don't indicate treatment failure. Setting a goal of losing 1-2 pounds per week provides a realistic expectation that aligns with clinical trial data.
Maintenance of weight loss requires continued treatment with semaglutide. Research indicates that when patients discontinue therapy, weight regain typically occurs within months without sustained dietary and exercise changes. PlexusDx supports long-term management through ongoing access to compounded semaglutide injections at consistent pricing, allowing you to maintain results without the burden of escalating costs.
Some patients reach a weight loss plateau where progress slows despite continued medication use. This can reflect reaching a new metabolic set point or adaptation to the medication. Discussing plateau strategies with your healthcare provider—such as increasing physical activity, adjusting macronutrient intake, or exploring combination therapies like GLP-Squared Injection that pairs semaglutide with tirzepatide—can reinitiate progress toward your goal weight.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How much weight can I realistically expect to lose in the first month?
Most patients lose 2-5 pounds in the first month as appetite decreases and eating patterns shift. Initial losses include both fat and water weight. Significant, measurable fat loss typically accelerates by week 4-6 as your body fully adjusts to the medication and caloric deficit deepens.
What percentage of body weight do clinical trials show people lose on semaglutide?
STEP clinical trials demonstrated average weight loss of 9.2% to 17.4% of baseline body weight over 68 weeks, with higher doses producing greater reductions. Individual results ranged from 5% to over 20% depending on dose, duration, lifestyle factors, and genetic predisposition to GLP-1 sensitivity.
Does PlexusDx compounded semaglutide produce the same weight loss results as brand-name Ozempic?
Yes, compounded semaglutide from licensed 503A pharmacies contains identical active ingredient and produces equivalent weight loss outcomes when dosed properly. PlexusDx injections start at just $149 monthly, making consistent, effective treatment accessible without insurance while maintaining the clinical results you expect.
What happens to weight loss if I stop taking semaglutide?
Research shows that weight regain typically begins within weeks of stopping semaglutide, with most regained weight returning within 12 months without sustained dietary changes. Long-term weight maintenance usually requires continuing treatment, which PlexusDx supports through affordable, consistent pricing at $149 monthly for injections.
How does genetic testing help predict my personal weight loss on semaglutide?
PlexusDx Precision Peptide Genetic Test ($99 add-on after first month) analyzes variants in GLP1R, GIPR, FTO, and MC4R genes that influence appetite regulation and metabolic response. This identifies your genetic predisposition toward stronger or slower GLP-1 responses, helping personalize your dose and treatment plan for optimal results.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What Will Happen if You Stop Taking Ozempic?
Navigating Long-Term Weight Management: Does Ozempic Need to Be Taken for Life?